Severity of COVID-19 in patients with lung cancer: evidence and challenges
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Severity of COVID-19 in patients with lung cancer: evidence and challenges
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 3, Pages e002266
Publisher
BMJ
Online
2021-03-19
DOI
10.1136/jitc-2020-002266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor types
- (2020) X. Zhao et al. ANNALS OF ONCOLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Testing for COVID-19 in lung cancer patients
- (2020) A. Passaro et al. ANNALS OF ONCOLOGY
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- NCI’s Work to Advance Cancer Research while Responding to the COVID-19 Pandemic
- (2020) Dinah S. Singer CANCER CELL
- Cancer Research after COVID-19: Where Do We Go from Here?
- (2020) Lauren E. Colbert et al. CANCER CELL
- The future of cancer research after COVID-19 pandemic: recession?
- (2020) Hampig Raphael Kourie et al. Future Oncology
- Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
- (2020) Melissa Bersanelli Immunotherapy
- Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19).
- (2020) Jeremy Lyle Warner et al. JOURNAL OF CLINICAL ONCOLOGY
- Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic
- (2020) Sameera Kumar et al. Journal of Thoracic Oncology
- Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
- (2020) Anne-Marie C. Dingemans et al. Journal of Thoracic Oncology
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
- (2020) Dmitri Nepogodiev et al. LANCET
- Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
- (2020) Jianbo Tian et al. LANCET ONCOLOGY
- Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak
- (2020) Zhongxing Liao et al. LUNG CANCER
- How is biomedical research funding faring during the COVID-19 lockdown?
- (2020) Paul Webster NATURE MEDICINE
- Impact of COVID-19 on oncology clinical trials
- (2020) Samik Upadhaya et al. NATURE REVIEWS DRUG DISCOVERY
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
- (2020) Matthias Guckenberger et al. RADIOTHERAPY AND ONCOLOGY
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak
- (2020) Mengyuan Dai et al. Cancer Discovery
- Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers
- (2020) Jia Luo et al. Cancer Discovery
- COVID-19 and smoking: A systematic review of the evidence
- (2020) Constantine Vardavas et al. Tobacco Induced Diseases
- Challenges in lung cancer therapy during the COVID-19 pandemic
- (2020) Luana Calabrò et al. Lancet Respiratory Medicine
- Tobacco smoking and COVID-19 infection
- (2020) Richard N van Zyl-Smit et al. Lancet Respiratory Medicine
- Sex difference and smoking predisposition in patients with COVID-19
- (2020) Hua Cai Lancet Respiratory Medicine
- Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19
- (2020) Daniel A. Goldstein et al. JAMA Oncology
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
- (2020) Jing Yu et al. JAMA Oncology
- Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- COVID-19 in patients with lung cancer
- (2020) J. Luo et al. ANNALS OF ONCOLOGY
- Cancer Patients and Risk of Mortality for COVID-19
- (2020) Giuseppe Curigliano CANCER CELL
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
- (2020) Camille Maringe et al. LANCET ONCOLOGY
- Cancer Research: The Lessons to Learn from COVID-19
- (2020) Chris Bailey et al. Cancer Discovery
- COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective
- (2020) Michelle Marcum et al. Cancer Medicine
- ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
- (2020) Antonio Passaro et al. ESMO Open
- LBA75 Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)
- (2020) J. Baena Espinar et al. ANNALS OF ONCOLOGY
- LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
- (2020) P. Grivas et al. ANNALS OF ONCOLOGY
- LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
- (2020) T.M. Wise-Draper et al. ANNALS OF ONCOLOGY
- 1670O Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory and emerging Infections Consortium, WHO Coronavirus Clinical Characterisation Consortium
- (2020) C. Palmieri et al. ANNALS OF ONCOLOGY
- COVID-19 and Cancer: Current Challenges and Perspectives
- (2020) Ziad Bakouny et al. CANCER CELL
- Dutch Oncology COVID-19 Consortium (DOCC): outcome of COVID-19 in patients with cancer in a nationwide cohort study
- (2020) K. de Joode et al. EUROPEAN JOURNAL OF CANCER
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
- COVID-19 in patients with cancer: managing a pandemic within a pandemic
- (2020) Leora Horn et al. Nature Reviews Clinical Oncology
- Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
- (2020) Antonio Calles et al. Frontiers in Oncology
- Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients
- (2020) Paul Hofman Translational Lung Cancer Research
- The impact of the COVID-19 pandemic on lung cancer patients
- (2020) Zhou Sha et al. Annals of Palliative Medicine
- Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective
- (2020) Hatoon Bakhribah et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Lung cancer control in the UK hit badly by COVID-19 pandemic
- (2020) Elizabeth Gourd LANCET ONCOLOGY
- Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic
- (2020) Holly E. Hartman et al. JAMA Oncology
- The innate immune architecture of lung tumors and its implication in disease progression
- (2019) Simon Milette et al. JOURNAL OF PATHOLOGY
- Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
- (2019) Kari M. Morrissey et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search